Search Results
Mar 12, 2026, 09:00 ET The Ritz-Carlton Yacht Collection Unveils a New Winter 2027-2028 Season of Voyages Aboard Evrima, Ilma, and Luminara
Puerto Chiapas, each revealing distinct cultural character and coastal beauty. In addition, two seven-night voyages from San Juan to Panama City offer a rare opportunity to pass through the Panama Canal, where guests can witness its architectural marvels from the private terraces of Evrima's all-suite
More news about: Marriott International, Inc.
Mar 12, 2026, 08:45 ET Express Celebrates Top Performers and Purpose‑Driven Leadership at International Leadership Conference in Nashville
helped shape countless careers while fostering environments where employees and franchise owners feel supported and empowered. His steady leadership and rare combination of humility and intensity left a lasting impression on Bob Funk Sr., who personally supported the creation of this award in Gill's honor.Bill
More news about: Express Services dba Express Employment Professionals
Mar 12, 2026, 08:41 ET Dr. Ronn Hale II Announces National Book Tour for "The Power of a Kingdom Mindset," A Blueprint for Leadership, Identity, and Generational Impact
Cleveland, Chicago, Pittsburg, Atlanta, Detroit, and the Washington, D.C. area. Known as "The Kingdom Mindset Strategist," Dr. Hale brings a rare combination of church leadership and marketplace credibility to the national conversation around identity, mental resilience, and generational leadership.
More news about: Dr. Ronn Hale
Mar 12, 2026, 08:01 ET American College of Medical Genetics and Genomics (ACMG) Clinical Genetics Meeting: Genomics presents new research highlighting underdiagnosis of rare genetic disorders
New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE, March 12,
More news about: Genomics Limited
Mar 12, 2026, 08:00 ET MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
https://globalrarediseasecommission.com/pressrelease-2024eoyreport/Rare Diseases: Individually Rare, Collectively Common. The Lancet Diabetes & Endocrinology, vol. 11, no. 3, 2023.Pandey, R., et al. "A meta-analysis of diagnostic yield and clinical utility of genome and exome sequencing in pediatric rare and undiagnosed genetic
More news about: MyOme, Inc
Mar 12, 2026, 08:00 ET Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
Officer. Dr. Hayward brings more than 26 years of global experience in the healthcare industry, including leadership in oncology, haemato-oncology, and rare diseases, with the last six years focused on radiopharmaceuticals and translational medicine.
More news about: Ratio Therapeutics Inc.
Mar 12, 2026, 08:00 ET Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference
Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other rare disease indications with significant unmet need, presented an oral clinical trial update on (Z)-endoxifen at the MDA Clinical & Scientific Conference
More news about: Atossa Therapeutics Inc
Mar 12, 2026, 08:00 ET Locksley Achieves 99.5% Purity Antimony Trioxide, Advancing U.S. Supply Chain Capability
Limited is focused on critical minerals in the United States of America. The Company is actively advancing the Mojave Project in California, targeting rare earth elements (REEs) and antimony. Locksley is executing a mine-to-market strategy for antimony, aimed at re-establishing domestic supply chains for
More news about: Locksley Resources
Mar 12, 2026, 07:58 ET Pierre Fabre Pharmaceuticals Announces Type A Meeting Agreed with U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA)
Pharmaceuticals and Pierre Fabre LaboratoriesThe mission of Pierre Fabre Pharmaceuticals (PFP) is to deliver breakthrough therapies in oncology and rare diseases to patient populations with high unmet needs and limited treatment options. Our belief is that every time we care for a single person, we make
More news about: Pierre Fabre Pharmaceuticals
Mar 12, 2026, 07:30 ET Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
immunotherapy.Cohort B: There has been a total of twenty-five (25) SOC-related grade 3 AEs, of which four (4) are considered common or rare side effects of immune checkpoint inhibitors (three grade 3 and one grade 4).The safety data for patients who received INT230-6 plus SOC
More news about: Intensity Therapeutics Inc.
Mar 12, 2026, 07:09 ET Newport LLC Welcomes AI and Cybersecurity Strategist George Tsantes as Partner to Help Mid-Market and Enterprise Leaders Navigate the Intelligent Era
35 years at the intersection of financial services, AI, and cybersecurity and boardroom advisory experience trusted by global firms, Tsantes brings rare, deployable expertise to Newport's growing mid-Atlantic advisory team.
More news about: Newport LLC
Mar 12, 2026, 06:00 ET More Perfect Partners with Generation Citizen to Incorporate Digital Media Literacy into Experiential Civic Education and Expand High School Voter Registration Efforts
Project, and RISE Vote 2026, a nonpartisan high school voter registration and pre-registration initiative."Generation Citizen has built something rare: a civic education model that does not just teach young people about democracy, but empowers them to engage with it," said John Bridgeland, Founder
More news about: More Perfect
Mar 12, 2026, 04:58 ET ImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026
March 12, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a biopharmaceutical company developing treatments for rare diseases, announced that they will participate in Bio-Europe Spring 2026, held in Lisbon, Portugal, from March 23rd to 25th, 2026, to conduct strategic
More news about: ImmunoForge Co., Ltd.
Mar 12, 2026, 04:25 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 12, 2026, 04:21 ET Des chefs-d'œuvre d'artisanat, de gastronomie et de culture : la «JAPAN SUI COLLECTION à Paris » captive 200 leaders européens au Royal Monceau
pionnières - comme l'application d'une laque traditionnelle sur du cuir véritable, un concept entièrement nouveau pour le marché européen - combinée à la rare opportunité d'entendre l'artiste lui-même partager les « histoires inédites » et la passion qui se cachent derrière ses créations, a eu un impact profond
More news about: Cabinet Office, Government of Japan
Mar 12, 2026, 04:18 ET Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE
RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of RARE during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 11, 2026, 20:01 ET The Urology Foundation launches bold #NameIt campaign tapping into surprising creativity of British men's anatomy nicknames - from Big Ben to Long Dong Silver
humour-led creative to overcome embarrassment, a key barrier preventing many men from discussing intimate symptoms or seeking help.Penile cancer is rare but rising, with more than 760 men diagnosed in the UK each year. Most cases are seen in men aged over 50 but an increasing number of younger people
More news about: The Urology Foundation
Mar 11, 2026, 20:01 ET The Urology Foundation launches bold #NameIt campaign tapping into surprising creativity of British men's anatomy nicknames - from Big Ben to Long Dong Silver
humour-led creative to overcome embarrassment, a key barrier preventing many men from discussing intimate symptoms or seeking help.Penile cancer is rare but rising, with more than 760 men diagnosed in the UK each year. Most cases are seen in men aged over 50 but an increasing number of younger people
More news about: The Urology Foundation
Mar 11, 2026, 15:00 ET Seniors Helping Seniors® In-Home Care Services Expands in Pittsburgh
family has operated multiple small businesses from the 1960s through the 2020s. During her teenage years, her father was diagnosed with Pick's disease, a rare form of dementia. Determined to keep him at home, Radevski's mother became his primary caregiver, with Radevski and her brothers stepping in to help.
More news about: Seniors Helping Seniors
Mar 11, 2026, 13:30 ET Wynn Las Vegas Debuts Art Collaboration at Zero Bond Las Vegas
meaningful connection," said Scott Sartiano, Founder of Zero Bond. "Bringing a collection of this caliber to Wynn Las Vegas gives our members and guests the rare opportunity to experience extraordinary works up close. It is about creating an environment where art is integrated into the setting and becomes part
More news about: Wynn Las Vegas
Mar 11, 2026, 13:03 ET InterContinental New York Times Square unveils a unique Broadway Immersion Package for Broadway's 2026 spring season
$3,500+ package, available March 27 – June 6, 2026, offering a two-night stay with premium Broadway tickets, curated Broadway access, iconic dining, and rare behind-the-scenes experiences—bringing the magic of the stage into every moment of your stay.NEW YORK,
More news about: InterContinental New York Times Square
Mar 11, 2026, 12:01 ET Mothers Exposure to Microbes Protect their Newborn Babies Against Infection
pregnancy, the natural transfer of these germ-fighting antibodies from mothers to babies in the womb protect the vast majority against infection. In the rare situation when these antibodies are low in mothers or inefficiently transferred, babies are at much higher risk for infection." Exploring
More news about: Cincinnati Children's Hospital Medical Center
Mar 11, 2026, 11:45 ET REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for
More news about: REGENXBIO Inc.
Mar 11, 2026, 11:00 ET Epidemiology Database: DelveInsight Unveils AI-Powered Platform Analyzing Patient Burden and Forecasts Across 500+ Diseases
pipelines.Includes extensive coverage of rare and ultra-rare disease indications, powered by DelveInsight's deep expertise and a uniquely comprehensive epidemiology repository, positioning DelveInsight as a recognized industry leader in rare disease intelligence.Provides multi-indication,
More news about: DelveInsight Business Research, LLP
Mar 11, 2026, 11:00 ET FILMCARD USA Releases MARVEL Digital Comics Full Series Collections
collectors something extraordinary: the ability to own and access Marvel's complete legacy series. "Now fans and collectors everywhere can access rare and iconic issues without worrying about cost, condition, storage, organization, or subscription fees," said Gary Van Emburgh, Managing Partner of GIT
More news about: FILMCARD USA LLC